Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / INFORCE™ 3 Earns Administration and Duration Label Claims
Added convenience and lasting protection against bovine respiratory disease
PARSIPPANY, N.J., Jan. 19, 2017 — Protection against respiratory disease early in life with INFORCE™ 3 helps calves stay healthy, develop to their full genetic potential and reduce the risk of illness later in life. Protecting young calves with INFORCE 3 is now easier than ever. INFORCE 3, the top selling cattle vaccine on the market1, has earned a single nostril administration claim to make it more convenient to administer.
Studies demonstrated that when the full 2-mL dose was administered into a single nostril in neonatal calves, INFORCE 3 protected against respiratory disease caused by infectious bovine rhinotracheitis (IBR)virus, bovine respiratory syncytial virus (BRSV) and parainfluenza 3 (PI3) virus.
In additional studies, INFORCE 3 also demonstrated the ability to override maternal antibodies to moderate IBR respiratory disease for at least 15 weeks and provided IBR respiratory protection for more than six months in IBR-naïve neonatal calves.
“INFORCE 3 delivers levels of protection and duration of immunity unmatched by any other intranasal vaccine,” said Nathan Voris, DVM, MBA, senior marketing manager with Zoetis. “Providing effective, long-lasting protection for the young calf is a big deal because illness during the calf’s first 60 days of life can set them back for their entire lifetime. Veterinarians and cattle producers utilize INFORCE 3 more than any other vaccine because they have observed the safe and effective respiratory protection it provides.”
Research underscores the benefits of INFORCE 3 Challenge studies investigating the efficacy of INFORCE 3 have demonstrated unsurpassed levels of protection for young calves.2-6
These studies verify that vaccination of neonatal calves with INFORCE 3 offers an effective strategy for preventing BRSV respiratory disease and stimulates long-lasting IBR respiratory protection, even in the presence of IBR maternal antibodies.
“The fact INFORCE 3 prevents BRSV respiratory disease and has now been shown to protect calves against IBR respiratory disease for at least six months should provide additional confidence for everyone working to build successful calf immunization programs,” said Dr. Voris.
INFORCE 3 from Zoetis is the first and only respiratory vaccine that prevents respiratory disease caused by BRSV while also aiding in the prevention of IBR and PI3. Developed specifically for needle-free intranasal administration, INFORCE 3 has shown excellent efficacy in helping to prevent respiratory disease and reduce viral shedding.2-7
The vaccine contains proprietary temperature-sensitive IBR and PI3 viral strains, as well as naturally temperature-sensitive BRSV. This unique formulation stimulates protective immunity in the nasal passages, where respiratory infections start, while also priming the immune system for a rapid memory response to subsequent vaccination or disease challenge. INFORCE 3 is safe for use in all types, ages and classes of calves, including neonatal calves and weaned and high-stress stocker calves.
To learn more about INFORCE 3 and how it supports rapid, complete immune response, talk to your Zoetis representative or veterinarian. For additional resources about pneumonia prevention, visit DairyWellness.com
About Zoetis Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For further information contact: Megan Lehman Zoetis908-472-1249 firstname.lastname@example.orgLindsey LangemeierBader Rutter402email@example.com
References:1 Animalytix® data, Zoetis Inc., September 2016.2 Mahan SM, Sobecki B, Johnson J, et al. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protecting seronegative and seropositive calves against respiratory disease. J Am Vet Med Assoc. 2016;248(11):1280-1286.3 Data on file, Study Report No. 3131R-60-08-548, Zoetis Inc.4 Data on file, Study Report No. 3131R-60-08-557, Zoetis Inc.5 Data on file, Study Report No. 3131R-60-09-669, Zoetis Inc.6 Data on file, Study Report No. 3131R-60-09-720, Zoetis Inc.7 Data on file, Study Report No. 3131R-60-08-568, Zoetis Inc.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.